ArticleInternational journal of surgery case reports2025
Life-saving hip disarticulation following necrotizing myofasciitis from invasive mucormycosis after blast injury: A case report.
Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Hip disarticulation and external hemipelvectomy for infectious indications: a systematic review.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2026Pooled it
- Upper limb mucormycosis in a patient with acute lymphoblastic leukemia: a case report.International journal of surgery case reports · 2026Article
- Time against tissue: case reports of fungal necrotizing fasciitis and the cost of delayed aggressive interventions.BMC infectious diseases · 2025Article
- Management and Surgical Dressing Protocol for Cutaneous Mucormycosis After a Blast Injury: A Case Report.The American journal of case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionNecrotizing myofasciitis is a rapidly progressing, life-threatening infection involving deep soft tissues, often caused by bacterial pathogens. However, fungal etiologies such as invasive mucormycosis, particularly in trauma patients, are rare and associated with high morbidity. Blast injuries create hypoxic environments conducive to fungal proliferation, complicating clinical management and often necessitating aggressive surgical interventions such as amputation. PRESENTATION OF CASE: We present the case of a 26-year-old male with no prior medical history, who sustained multiple injuries from a bomb blast. The patient developed necrotizing myofasciitis secondary to invasive mucormycosis (Rhizopus species) and Streptococcus pyogenes. Despite repeated debridements and initiation of antifungal therapy with liposomal amphotericin B, the infection progressed rapidly. Acute kidney injury, severe sepsis, and extensive tissue necrosis prompted life-saving hip disarticulation. Postoperatively, the patient stabilized and transitioned to rehabilitation with a multidisciplinary care approach. DISCUSSION: This case highlights the challenges of managing necrotizing myofasciitis caused by mucormycosis after blast trauma. Tissue ischemia favored fungal growth, with Rhizopus and Streptococcus pyogenes identified as pathogens. Liposomal amphotericin B and a multidisciplinary approach were critical in managing systemic complications, including sepsis and acute kidney injury.
conclusionInvasive mucormycosis following trauma is a rare but devastating condition requiring early recognition, and a combination of aggressive surgical and medical management. This case highlights the critical role of hip disarticulation as a life-saving measure in refractory necrotizing infections, emphasizing the importance of a multidisciplinary approach to optimize outcomes in complex clinical scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.